N-[(2-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid)
C23H19F6N5O6 — CID 117077885
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid)
N-[(2-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid) (PubChem CID 117077885) has the molecular formula C23H19F6N5O6 and a molecular weight of 575.42 g/mol. Its IUPAC name is N-[(2-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | N-[(2-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid) |
|---|---|
| PubChem CID | 117077885 |
| Molecular Formula | C23H19F6N5O6 |
| Molecular Weight | 575.42 g/mol |
| Exact Mass | 575.12 |
| IUPAC Name | N-[(2-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1H-indazole-3-carboxamide;bis(2,2,2-trifluoroacetic acid) |
| SMILES | COc1ccccc1CNC(=O)c1n[nH]c2cc(-c3cn[nH]c3)ccc12.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C19H17N5O2.2C2HF3O2/c1-26-17-5-3-2-4-13(17)9-20-19(25)18-15-7-6-12(8-16(15)23-24-18)14-10-21-22-11-14;2*3-2(4,5)1(6)7/h2-8,10-11H,9H2,1H3,(H,20,25)(H,21,22)(H,23,24);2*(H,6,7) |
| InChIKey | ISFWJYASRMSGGW-UHFFFAOYSA-N |
| XLogP | 4.16 |
| TPSA | 170.29 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 575.42 |
| LogP ≤ 5 | 4.16 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117077885 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.